This page is part of the FHIR Specification (v3.3.0: R4 Ballot 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Patient Care Work Group | Maturity Level: N/A | Ballot Status: Informative |
Definition for Code System AllergyIntoleranceType
{ "resourceType": "CodeSystem", "id": "allergy-intolerance-type", "meta": { "lastUpdated": "2018-04-03T12:05:46.262+10:00" }, "text": { "status": "generated", "div": "<div>!-- Snipped for Brevity --></div>" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode": "pc" }, { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status", "valueString": "Trial Use" }, { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm", "valueInteger": 3 } ], "url": "http://hl7.org/fhir/allergy-intolerance-type", "identifier": { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.4.642.1.132" }, "version": "3.3.0", "name": "AllergyIntoleranceType", "status": "draft", "experimental": false, "date": "2018-04-03T12:05:46+10:00", "publisher": "HL7 (FHIR Project)", "contact": [ { "telecom": [ { "system": "url", "value": "http://hl7.org/fhir" }, { "system": "email", "value": "fhir@lists.hl7.org" } ] } ], "description": "Identification of the underlying physiological mechanism for a Reaction Risk.", "caseSensitive": true, "valueSet": "http://hl7.org/fhir/ValueSet/allergy-intolerance-type", "content": "complete", "concept": [ { "code": "allergy", "display": "Allergy", "definition": "A propensity for hypersensitivity reaction(s) to a substance. These reactions are most typically type I hypersensitivity, plus other \"allergy-like\" reactions, including pseudoallergy." }, { "code": "intolerance", "display": "Intolerance", "definition": "A propensity for adverse reactions to a substance that is not judged to be allergic or \"allergy-like\". These reactions are typically (but not necessarily) non-immune. They are to some degree idiosyncratic and/or individually specific (i.e. are not a reaction that is expected to occur with most or all patients given similar circumstances)." } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.